Open access peer-reviewed chapter

ADAM Proteases as Novel Therapeutic Targets in Chronic Kidney Disease

By Monika Göőz

Submitted: February 4th 2011Reviewed: January 5th 2012Published: March 16th 2012

DOI: 10.5772/26187

Downloaded: 1759

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Monika Göőz (March 16th 2012). ADAM Proteases as Novel Therapeutic Targets in Chronic Kidney Disease, Chronic Kidney Disease Monika Göoz, IntechOpen, DOI: 10.5772/26187. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/chronic-kidney-disease/adam-proteases-as-novel-therapeutic-targets-in-chronic-kidney-disease" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1759total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Severity and Stages of Chronic Kidney Disease

By Syed Ahmed and Gerard Lowder

Related Book

First chapter

Kinetic Modeling and Adequacy of Dialysis

By Malgorzata Debowska, Bengt Lindholm and Jacek Waniewski

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us